- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04016961
Human-Animal Interaction to Promote Recovery Following Pediatric Brain Injury (AAT)
9. Juli 2019 aktualisiert von: Children's Hospital Medical Center, Cincinnati
Huma-Animal Interaction to Promote Recovery Following Pediatric Brain Injury
This study evaluates the addition of therapy dogs in inpatient physical and occupational therapy.
Data will be collected across 10 PT and 10 OT sessions, half of which will incorporate a therapy dog.
Studienübersicht
Status
Unbekannt
Intervention / Behandlung
Detaillierte Beschreibung
Children with acquired brain injuries (ABI) treated on an inpatient rehabilitation unit are at significant risk for long term functional impairment, highlighting the importance of maximizing the effectiveness and utilization of inpatient rehabilitation therapies.
The proposed study seeks to explore the value of animal-assisted therapy (AAT) during inpatient rehabilitation following pediatric ABI.
Investigators will employ a within subjects cross-over trial; all participants will have a volunteer dog involved in 50% of their physical therapy (PT) and occupational therapy (OT) sessions over a 2-week study period.
AAT will consist of integration of a dog from the hospital volunteer dog program in PT and OT sessions, while the non-AAT condition will be treatment as usual (TAU) as identified by the patients' treatment team.
Information regarding patient engagement/participation in therapy, affect, and physiological variables will be collected during each session.
Session notes will also be coded for additional qualitative information.
Qualitative feedback from patients and families, therapists, medical teams, and dog handlers will also be collected throughout the project to examine feasibility and satisfaction with the intervention as well as potential barriers and areas for improvement.
Investigators will 1) examine the effect of AAT on level of patient participation and patient affect during PT and OT sessions, 2) Explore the effect of AAT on functional outcomes using a historic cohort comparison group, and 3) explore the physiological response of patients, and examine a number of variables (injury type/severity, child sex and anthropomorphism, therapist factors, and dog handler factors) to begin to determine which patients are most likely to benefit from AAT during inpatient rehabilitation for ABI.
Studientyp
Interventionell
Einschreibung (Voraussichtlich)
40
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienkontakt
- Name: Megan Narad, PhD
- Telefonnummer: 513-803-8902
- E-Mail: megan.narad@cchmc.org
Studienorte
-
-
Ohio
-
Cincinnati, Ohio, Vereinigte Staaten, 45229
- Cincinnati Children's Hospital Medical Center
-
Kontakt:
- Megan Narad, PhD
- Telefonnummer: 513-803-8902
- E-Mail: megan.narad@cchmc.org
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
6 Jahre und älter (Kind, Erwachsene, Älterer Erwachsener)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Diagnosis: Participants must be on the inpatient rehabilitation unit for treatment of an acquired brain injury (TBI, brain tumor, infection, stroke, etc)
- Consent: The family must provide informed consent by parents or legal guardians
- Assent: The adolescent must provide a signature indicating assent to participate in the study.
- Age at time of screening: 6 years old and older with no upper limit
- Responsiveness: Rancho score greater than 2 (or equivalent) at the time of enrollment (as noted in medical chart)
Exclusion Criteria:
- Animals: Participant has a significant allergy to dogs or have a significant fear of dogs.
- Disease: Participant has a communicable disease that may pose a risk to dog or dog handler or a compromised immune system where interacting with dog and/or handler would be of significant risk to patient.
- Responsiveness: Rancho score of 2 (or equivalent) or less
- Cognitive issues: Participants with pre-injury/pre-diagnosis of developmental delay, autism, and/or patients who are non-verbal will be excluded.
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Animal Assisted Therapy - Dog Session
Therapy dog added to PT and OT session
|
therapy dog added to inpatient PT and OT session
|
Aktiver Komparator: Treatment as usual - No Dog session
No dog added to PT and OT session - PT and OT session as usual standard of care
|
PT and OT as usual without the addition of therapy dog
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Patient Participation - AAT
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Patient participation during AAT sessions will be assessed using the Pittsburgh Rehabilitation Participation Scale (PRPS)The PRPS is a 6-item Likert-type, clinician-rated measure that quantifies observed patient participation in their therapy session.
Therapists report their observations regarding patient's completion of exercises, effort applied to exercises, and level of support needed to complete activities.
Scores range from 1 (None) to 6 (excellent).
Therapists will complete this measure at the end of each AAT session.
Ratings across the 5 (on average) AAT sessions will be used to create an patient participation - AAT score.
|
Throughout study completion, an average of 2 weeks
|
Patient Participation - TAU
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Patient participation during TAU sessions will be assessed using the Pittsburgh Rehabilitation Participation Scale (PRPS)The PRPS is a 6-item Likert-type, clinician-rated measure that quantifies observed patient participation in their therapy session.
Therapists report their observations regarding patient's completion of exercises, effort applied to exercises, and level of support needed to complete activities.
Scores range from 1 (None) to 6 (excellent).
Therapists will complete this measure at the end of each TAU session.
Scores across the 5 (on average) TAU sessions will be used to create a single patient participation - TAU score.
|
Throughout study completion, an average of 2 weeks
|
Objective session participation - AAT
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Objective session participation will be assessed via videotaped sessions for at least 2 AAT sessions.
Coders will provide an objective measure of participation by rating patient in session participation using the Pittsburgh Rehabilitation Participation Scale (PRPS).
Coders will score participation using the PRPS and rate the participants level of participation from 1 (None) to 6 (Excellent).
These coder ratings will be used to create an overall objective session participation AAT score.
|
Throughout study completion, an average of 2 weeks
|
Objective session participation - TAU
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Objective session participation will be assessed via videotaped sessions for at least 2 TAU sessions.
Coders will provide an objective measure of participation by rating patient in session participation using the Pittsburgh Rehabilitation Participation Scale (PRPS).
Coders will score participation using the PRPS and rate the participants level of participation from 1 (None) to 6 (Excellent).
These coder ratings will be used to create an overall objective session participation TAU score.
|
Throughout study completion, an average of 2 weeks
|
Patient Affect - AAT
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Patient affect will be assessed via the Symptom Inventory Scale - Short.This measure is a 4-item measure, where the patient reports the degree (from 0-10) they are experiencing each feeling/condition presented (Happy, fatigue, distraction, irritability).
The patient will be asked to complete this measure at the beginning and end of each AAT session.
These ratings will be used to create happy, fatigue, distracted, and irritable - AAT scores.
Greater scores are reflective of greater levels of that emotion.
|
Throughout study completion, an average of 2 weeks
|
Patient Affect - TAU
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Patient affect will be assessed via the Symptom Inventory Scale - Short.This measure is a 4-item measure, where the patient reports the degree (from 0-10) they are experiencing each feeling/condition presented (Happy, fatigue, distraction, irritability).
The patient will be asked to complete this measure at the beginning and end of each TAU session.
These ratings will be used to create happy, fatigue, distracted, and irritable - TAU scores.
Greater scores are indicative of greater levels of that emotion.
|
Throughout study completion, an average of 2 weeks
|
Objective mood assessment - AAT
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Objective mood assessment will be completed for at least 2 AAT sessions via coding of video taped sessions.
Coders naïve to hypotheses will assess the percentage of time the patient displays positive and negative affect.
Greater scores.
Greater scores are indicative of greater levels of positive and negative affect.
Scores across all coded AAT sessions will be used to create a positive affect-AAT score and negative affect-AAT score.
|
Throughout study completion, an average of 2 weeks
|
Objective mood assessment - TAU
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Objective mood assessment will be completed for at least 2 TAU sessions via coding of video taped sessions.
Coders naïve to hypotheses will assess the percentage of time the patient displays positive and negative affect.
Greater scores.
Greater scores are indicative of greater levels of positive and negative affect.
Scores across all coded TAU sessions will be used to create a positive affect-TAU score and negative affect-TAU score.
|
Throughout study completion, an average of 2 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Heart rate- AAT
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Heart rate will be collected using an Empatica E4 wristband during each of the AAT sessions.
The patient will wear the wrist band during all sessions, and data collected during AAT sessions will be summarized as heart rate - AAT,
|
Throughout study completion, an average of 2 weeks
|
Temperature - AAT
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Temperature will be collected using an Empatica E4 wristband during each of the AAT sessions.
The patient will wear the wrist band during all sessions, and data collected during AAT sessions will be summarized as temperature-AAT.
|
Throughout study completion, an average of 2 weeks
|
Galvanic Skin Response - AAT
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Galvanic skin response (GSR) will be collected using an Empatica E4 wristband during each of the AAT sessions.
The patient will wear the wrist band during all sessions, and data collected during AAT sessions will be summarized as GSR-AAT.
|
Throughout study completion, an average of 2 weeks
|
Heart Rate - Tau
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Heart rate will be collected using an Empatica E4 wristband during each of the TAU sessions.
The patient will wear the wrist band during all sessions, and data collected during TAU sessions will be summarized as heart rate - TAU.
|
Throughout study completion, an average of 2 weeks
|
Temperature - Tau
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Temperature, and galvanic skin response will be collected using an Empatica E4 wristband during each of the TAU sessions.
The patient will wear the wrist band during all sessions, and data collected during TAU sessions will be summarized as temperature-TAU.
|
Throughout study completion, an average of 2 weeks
|
Galvanic skin response - Tau
Zeitfenster: Throughout study completion, an average of 2 weeks
|
Galvanic skin response (GSR) will be collected using an Empatica E4 wristband during each of the TAU sessions.
The patient will wear the wrist band during all sessions, and data collected during TAU sessions will be summarized as GSR-TAU.
|
Throughout study completion, an average of 2 weeks
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Ermittler
- Hauptermittler: Megan Narad, PhD, Children's Hospital Medical Center, Cincinnati
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Voraussichtlich)
1. Juli 2019
Primärer Abschluss (Voraussichtlich)
31. Juli 2020
Studienabschluss (Voraussichtlich)
31. Juli 2020
Studienanmeldedaten
Zuerst eingereicht
3. Mai 2019
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
9. Juli 2019
Zuerst gepostet (Tatsächlich)
12. Juli 2019
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
12. Juli 2019
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
9. Juli 2019
Zuletzt verifiziert
1. Juli 2019
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- CIN001-AAT
- 1R21HD095132-01 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
NEIN
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Hirnverletzungen
-
National Institute of Mental Health (NIMH)AbgeschlossenBrain-MappingVereinigte Staaten
-
National Institute on Alcohol Abuse and Alcoholism...AbgeschlossenBrain-MappingVereinigte Staaten
-
Assistance Publique Hopitaux De MarseilleUnbekanntBrain Awake-ChirurgieFrankreich
-
University of Dublin, Trinity CollegeUnbekanntBrain Health Elite-Athleten im Ruhestand
-
National Institute of Mental Health (NIMH)RekrutierungGesunder Freiwilliger | Brain-MappingVereinigte Staaten
-
National Institute of Neurological Disorders and...RekrutierungGesund | Magnetresonanztomographie | Gesunder Freiwilliger | Erwachsene | fMRT | Brain-MappingVereinigte Staaten
-
National Institute of Neurological Disorders and...AbgeschlossenGesund | Blindheit | Brain-MappingVereinigte Staaten
-
National Institute of Mental Health (NIMH)AbgeschlossenfMRT | Gehirnerkrankung | Brain-Mapping | Genotyp | Allelic Frequencies of Genetic MarkersVereinigte Staaten
-
National Institute on Alcohol Abuse and Alcoholism...RekrutierungAlkohol trinken | Alkoholabhängigkeit | Alkoholismus | Alkoholbedingte Störungen | Brain-MappingVereinigte Staaten
-
Assiut UniversityAbgeschlossenBrain Voxel-basierte Morphometrie bei ManiaÄgypten
Klinische Studien zur AAT - Dog
-
Fujian Medical UniversityUnbekanntAnastomoseninsuffizienz | Rektumkarzinom | Laparoskopie
-
San Diego State UniversityRekrutierungDepression | Betonen | Schwangerschaft bezogen | Diskriminierung, Rasse | Problem der psychischen GesundheitVereinigte Staaten
-
University of California, San DiegoNational Institute of Mental Health (NIMH)AbgeschlossenSoziale AngststörungVereinigte Staaten
-
Yale UniversityVU University of AmsterdamAbgeschlossenTabakkonsumstörungVereinigte Staaten
-
University of North Carolina, Chapel HillRekrutierung
-
Universitätsklinikum Hamburg-EppendorfAbgeschlossenGlücksspiel, pathologischDeutschland
-
Brock UniversityNoch keine RekrutierungDepression | Multiple Sklerose | Entzündung | Verletzungen des Rückenmarks | Diät, gesund | Adhärenz, BehandlungKanada
-
Inova Health Care ServicesAbgeschlossenSchädel-Hirn-TraumaVereinigte Staaten
-
Johns Hopkins UniversityU.S. Army Medical Research and Development Command; Armed Forces Institute of...RekrutierungTrauma | WeichteilverletzungenVereinigte Staaten
-
Brock UniversityAbgeschlossenMultiple Sklerose | Entzündung | Muskeldystrophien | Verletzungen des Rückenmarks | Diät-GewohnheitKanada